Phase 3 COPD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have completed the full 52-week treatment period in one of the two related earlier studies (called GB43311 or GB44332)
Who may not be able to join:
- People who withdrew their consent or left the earlier study early before finishing it
- People whose study medication was permanently stopped at any point during the earlier study
- People who did not follow the earlier study's requirements closely enough — for example, by missing scheduled visits — as judged by the study investigator
- People who have been newly diagnosed with asthma (according to recognised medical guidelines) since joining the earlier study
- People who have developed a new, significant lung condition other than COPD since joining the earlier study — for example, pulmonary fibrosis, sarcoidosis, long-term blood clots in the lungs, primary pulmonary hypertension, or a condition called alpha-1-antitrypsin deficiency
- People who have developed a new, serious heart condition since joining the earlier study — including unstable heart disease, a heart attack, or a more severe level of heart failure (classified as Class III or IV by a standard medical rating system)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Clinical Trials, Hoffmann-La Roche
Phone: 888-662-6728
Australian sites
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
4 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Incidence of all adverse events (AEs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.